Litcius/Paper detail

Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT

Ryszard Swoboda, Myriam Labopin, Sebastian Giebel, Emanuele Angelucci, Mutlu Arat, Mahmoud Aljurf, Simona Sica, Jiří Pavlů, Gèrard Socié, Paolo Bernasconi, Luigi Rigacci, Johanna Tischer, Antonio M. Risitano, Montserrat Rovira, Riccardo Saccardi, Pietro Pioltelli, Gwendolyn Van Gorkom, Antonı́n Vı́tek, Bipin N. Savani, Alexandros Spyridonidis, Zinaida Perić, Arnon Nagler, Mohamad Mohty

2022Bone Marrow Transplantation23 citationsDOI

Topics & Concepts

FludarabineMedicineThioTEPABusulfanTotal body irradiationInternal medicineUnivariate analysisCyclophosphamideCumulative incidenceTransplantationAcute leukemiaSurgeryHematopoietic stem cell transplantationGastroenterologyOncologyAcute lymphocytic leukemiaIncidence (geometry)LeukemiaChemotherapyMultivariate analysisLymphoblastic LeukemiaPhysicsOpticsHematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia researchPolyomavirus and related diseases
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT | Litcius